Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00035269
Status:
COMPLETED
Last Update Posted:
2011-04-26
First Post:
2002-05-02
Brief Title:
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria S Pneumoniae Pneumonia
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia An Open-Label Non-Comparator Study
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria S pneumoniae
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A5951056 | None | None | None |